Divala T H, Lewis J, Bulterys M A, Lutje V, Corbett E L, Schumacher S G, MacPherson P
Helse Nord Tuberculosis Initiative, Kamuzu University of Health Sciences, Blantyre, Malawi.
TB Centre, London School of Hygiene & Tropical Medicine, London, UK.
Public Health Action. 2022 Mar 21;12(1):10-17. doi: 10.5588/pha.21.0022.
The identification of patients with symptoms is the foundation of facility-based TB screening and diagnosis, but underdiagnosis is common. We conducted this systematic review with the hypothesis that underdiagnosis is largely secondary to patient drop out along the diagnostic and care pathway.
We searched (up to 22 January 2019) MEDLINE, Embase, and Cinahl for studies investigating patient pathway to TB diagnosis and care at health facilities. We used Quality Assessment of Diagnostic Accuracy Studies 2 (QUADAS-2) to assess risk of bias. We reported proportions of patients with symptoms at each stage of the pathway from symptom screening to treatment initiation.
After screening 3,558 abstracts, we identified 16 eligible studies. None provided data addressing the full cascade of care from clinical presentation to treatment initiation in the same patient population. Symptom screening, the critical entry point for diagnosis of TB, was not done for 33-96% of participants with symptoms in the three studies that reported this outcome. The proportion of attendees with symptoms offered a diagnostic investigation (data available for 15 studies) was very low with a study level median of 38% (IQR 14-44, range 4-84).
Inefficiencies of the TB symptom screen-based patient pathway are a major contributor to underdiagnosis of TB, reflecting inconsistent implementation of guidelines to ask all patients attending health facilities about respiratory symptoms and to offer diagnostic tests to all patients promptly once TB symptoms are identified. Better screening tools and interventions to improve the efficiency of TB screening and diagnosis pathways in health facilities are urgently needed.
识别有症状的患者是基于医疗机构的结核病筛查和诊断的基础,但漏诊情况很常见。我们进行了这项系统评价,假设漏诊在很大程度上是由于患者在诊断和治疗过程中退出所致。
我们检索了(截至2019年1月22日)MEDLINE、Embase和Cinahl,以查找有关医疗机构中结核病诊断和治疗患者路径的研究。我们使用诊断准确性研究质量评估2(QUADAS-2)来评估偏倚风险。我们报告了从症状筛查到开始治疗的路径各阶段有症状患者的比例。
在筛选了3558篇摘要后,我们确定了16项符合条件的研究。没有一项研究提供了同一患者群体从临床表现到开始治疗的完整治疗流程数据。在报告了这一结果的三项研究中,33%-96%有症状的参与者未进行结核病诊断的关键切入点——症状筛查。接受诊断性检查的有症状就诊者比例(15项研究有数据)非常低,研究水平中位数为38%(四分位间距14%-44%,范围4%-84%)。
基于结核病症状筛查的患者路径效率低下是结核病漏诊的主要原因,这反映出在询问所有到医疗机构就诊的患者呼吸道症状以及一旦发现结核病症状就立即为所有患者提供诊断检查方面,指南的执行不一致。迫切需要更好的筛查工具和干预措施,以提高医疗机构中结核病筛查和诊断路径的效率。